Artículos de revistas
Transcription Factor NF-κB: An Update on Intervention Strategies
Fecha
2016-12Registro en:
Rajendran, Arvind; Inda, María Eugenia; Bagam, Prathyusha; Sahoo, Malaya K.; Osorio, Diana; et al.; Transcription Factor NF-κB: An Update on Intervention Strategies; Birkhauser Verlag Ag; Archivum Immunologiae Et Therapiae Experimentalis; 64; 6; 12-2016; 463-483
0004-069X
CONICET Digital
CONICET
Autor
Rajendran, Arvind
Inda, María Eugenia
Bagam, Prathyusha
Sahoo, Malaya K.
Osorio, Diana
Batra, Sanjay
Resumen
The nuclear factor (NF)-κB family of transcription factors are ubiquitous and pleiotropic molecules that regulate the expression of more than 150 genes involved in a broad range of processes including inflammation, immunity, cell proliferation, differentiation, and survival. The chronic activation or dysregulation of NF-κB signaling is the central cause of pathogenesis in many disease conditions and, therefore, NF-κB is a major focus of therapeutic intervention. Because of this, understanding the relationship between NF-κB and the induction of various downstream signaling molecules is imperative. In this review, we provide an updated synopsis of the role of NF-κB in DNA repair and in various ailments including cardiovascular diseases, HIV infection, asthma, herpes simplex virus infection, chronic obstructive pulmonary disease, and cancer. Furthermore, we also discuss the specific targets for selective inhibitors and future therapeutic strategies.